Advisor(s)

Dilshan Beligala

Confirmation

1

Document Type

Poster

Location

ONU McIntosh Center; Activities Room

Start Date

24-4-2026 10:00 AM

End Date

24-4-2026 10:50 AM

Abstract

Effects of Limb Dominance on Dopaminergic Neurodegeneration in a 6-OHDA Rat Model of Parkinson’s Disease Assessed by Immunoblotting

Jasin Porshiaa , Deanna Chaialeea , Dipesh Pokharelb,c , Kala Venkiteswaranb, c, d , Thyagarajan Subramanianb, c, d, Dilshan Beligalaa

aDepartment of Biological Sciences, Ohio Northern University, Ada, OH, USA

bDepartment of Neurosciences and Psychiatry, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

cDepartment of Neurology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

dDepartment of Neurology, Howard University, Washington, DC, USA

Parkinson’s disease (PD) is characterized by pronounced asymmetry compared to other neurodegenerative disorders such as multiple system atrophy (MSA) and Lewy body dementia (LBD). This asymmetry is typically evident at disease onset and a certain degree often persists throughout progression. The motor symptoms of PD are primarily linked to dopamine loss within the basal ganglia. Although dopaminergic degeneration occurs in both hemispheres, only a small proportion of patients exhibit symmetric motor symptoms. Despite this, the role of hemispheric lateralization in PD progression remains poorly understood. Paw preference in rats, analogous to human handedness, provides a useful model to study lateralized brain function. This study examines whether paw preference influences hemispheric vulnerability in a 6-hydroxydopamine (6-OHDA) model of PD, a neurotoxin-based model that selectively lesions dopaminergic neurons and produces robust unilateral degeneration. Specifically, it investigates whether limb dominance is associated with asymmetric dopaminergic degeneration and changes in protein expression. Immunoblotting is used to compare hemispheric expression of key dopaminergic markers: tyrosine hydroxylase (TH), dopa decarboxylase (DDC), and vesicular monoamine transporter 2 (VMAT2), across brain regions central to PD pathology. Preliminary analyses in control animals show no significant hemispheric differences, while data collection for 6- OHDA–treated animals is ongoing.

Open Access

Available to all.

Share

COinS
 
Apr 24th, 10:00 AM Apr 24th, 10:50 AM

Effects of Limb Dominance on Dopaminergic Neurodegeneration in a 6-OHDA Rat Model of Parkinson’s Disease Assessed by Immunoblotting

ONU McIntosh Center; Activities Room

Effects of Limb Dominance on Dopaminergic Neurodegeneration in a 6-OHDA Rat Model of Parkinson’s Disease Assessed by Immunoblotting

Jasin Porshiaa , Deanna Chaialeea , Dipesh Pokharelb,c , Kala Venkiteswaranb, c, d , Thyagarajan Subramanianb, c, d, Dilshan Beligalaa

aDepartment of Biological Sciences, Ohio Northern University, Ada, OH, USA

bDepartment of Neurosciences and Psychiatry, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

cDepartment of Neurology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

dDepartment of Neurology, Howard University, Washington, DC, USA

Parkinson’s disease (PD) is characterized by pronounced asymmetry compared to other neurodegenerative disorders such as multiple system atrophy (MSA) and Lewy body dementia (LBD). This asymmetry is typically evident at disease onset and a certain degree often persists throughout progression. The motor symptoms of PD are primarily linked to dopamine loss within the basal ganglia. Although dopaminergic degeneration occurs in both hemispheres, only a small proportion of patients exhibit symmetric motor symptoms. Despite this, the role of hemispheric lateralization in PD progression remains poorly understood. Paw preference in rats, analogous to human handedness, provides a useful model to study lateralized brain function. This study examines whether paw preference influences hemispheric vulnerability in a 6-hydroxydopamine (6-OHDA) model of PD, a neurotoxin-based model that selectively lesions dopaminergic neurons and produces robust unilateral degeneration. Specifically, it investigates whether limb dominance is associated with asymmetric dopaminergic degeneration and changes in protein expression. Immunoblotting is used to compare hemispheric expression of key dopaminergic markers: tyrosine hydroxylase (TH), dopa decarboxylase (DDC), and vesicular monoamine transporter 2 (VMAT2), across brain regions central to PD pathology. Preliminary analyses in control animals show no significant hemispheric differences, while data collection for 6- OHDA–treated animals is ongoing.